PRAMIPEXOLE GPPL pramipexole dihydrochloride 0.25 mg tablets blister pack

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
26-11-2017

Bahan aktif:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Boleh didapati daripada:

Arrotex Pharmaceuticals Pty Ltd

INN (Nama Antarabangsa):

pramipexole dihydrochloride monohydrate

Borang farmaseutikal:

Tablet, uncoated

Komposisi:

Excipient Ingredients: pregelatinised maize starch; silicon dioxide; povidone; magnesium stearate; mannitol

Laluan pentadbiran:

Oral

Unit dalam pakej:

10, 30, 100

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Ringkasan produk:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status kebenaran:

Licence status A

Tarikh kebenaran:

2014-09-23